Lim Jong-Min, Song Chang-Hyun, Park Su-Jin, Park Dong-Chan, Cho Hyung-Rae, Jung Go-Woon, Bashir Khawaja Muhammad Imran, Ku Sae Kwang, Choi Jae-Suk
#305 Marine Bio-Industry Development Center Glucan Corp. Gijan-gun Busan Korea.
Department of Anatomy and Histology College of Korean Medicine Daegu Haany University Gyeongsan-si Gyeongsanbuk-do Korea.
Food Sci Nutr. 2018 Oct 1;6(8):2036-2046. doi: 10.1002/fsn3.745. eCollection 2018 Nov.
This study was designed to observe the possible protective effects of a triple-fermented barley ( L.) extract (FBe) obtained by saccharification and using and in alleviating gastric damage induced by a hydrochloric acid (HCl) and ethanol (EtOH) mixture in mice. After oral administration of FBe (300, 200, and 100 mg/kg) followed by 1 hr before and after the single treatment of HCl/EtOH (H/E) mixture, the hemorrhagic lesion scores, histopathology of the stomach, gastric nitrate/nitrite content, lipid peroxidation, and antioxidant defense systems including catalase and superoxide dismutase activities were observed. Following a single oral treatment of H/E-induced gastric damages as measured by hemorrhagic gross lesions and histopathological gastric, ulcerative lesions were significantly and dose-dependently ( < 0.01 or < 0.05) inhibited in mice, when all three different doses of FBe were administered as compared to those in H/E control mice. In particular, FBe also increased gastric nitrate/nitrite content and strengthened the antioxidant defense, with a decrease in the level of gastric lipid peroxidation, but increased the activities of CAT and SOD. Moreover, the effects of FBe are comparable to that of ranitidine, a reference drug. The obtained results suggest that this fermented barley extract prevented mice from H/E-induced gastric mucosal damages through the suppression of inflammatory responses and oxidative stress-responsive free radicals. Thus, FBe can be useful to treat patients suffering from gastric mucosal disorders as a potent food supplement, and thereby, it would increase the necessity of application in the food industry.
本研究旨在观察通过糖化以及使用[具体物质1]和[具体物质2]获得的三发酵大麦提取物(FBe)对减轻盐酸(HCl)和乙醇(EtOH)混合物诱导的小鼠胃损伤的可能保护作用。在口服FBe(300、200和100mg/kg)后,在单次给予HCl/EtOH(H/E)混合物之前和之后1小时,观察出血性病变评分、胃组织病理学、胃硝酸盐/亚硝酸盐含量、脂质过氧化以及包括过氧化氢酶和超氧化物歧化酶活性在内的抗氧化防御系统。通过出血性大体病变和胃组织病理学溃疡病变测量,单次口服H/E诱导的胃损伤后,与H/E对照小鼠相比,当给予所有三种不同剂量的FBe时,小鼠的溃疡病变得到显著且剂量依赖性(P<0.01或P<0.05)抑制。特别是,FBe还增加了胃硝酸盐/亚硝酸盐含量并增强了抗氧化防御,同时降低了胃脂质过氧化水平,但增加了CAT和SOD的活性。此外,FBe的作用与参比药物雷尼替丁相当。所得结果表明,这种发酵大麦提取物通过抑制炎症反应和氧化应激反应性自由基,防止小鼠发生H/E诱导的胃黏膜损伤。因此,FBe作为一种有效的食品补充剂,可用于治疗患有胃黏膜疾病的患者,从而增加了其在食品工业中的应用必要性。